"I wouldn't be surprised if researchers and labs are looking for ways to activate SLC25A51 chemically to get the NAD+ flowing to SIRT3 without requiring fasting."
To what end ?
Fasting would be cheaper, easier and less time-consuming and would include all of the related, broad-spectrum effects that we also believe fasting may produce.
I guess if you're a pharma investor or existing, entrenched player it makes sense to go that direction.
As a consumer, however, I wonder why (pills that might convey a subset of the benefits of fasting) would be interesting in any way.
To what end ?
Fasting would be cheaper, easier and less time-consuming and would include all of the related, broad-spectrum effects that we also believe fasting may produce.
I guess if you're a pharma investor or existing, entrenched player it makes sense to go that direction.
As a consumer, however, I wonder why (pills that might convey a subset of the benefits of fasting) would be interesting in any way.